Methyldopa

— THERAPEUTIC CATEGORIES —
  • Hypertension

Methyldopa Generic Name & Formulations

General Description

Methyldopa 125mg, 250mg, 500mg; tabs.

Pharmacological Class

Central alpha agonist.

How Supplied

Tabs—100

Methyldopa Indications

Indications

Hypertension.

Methyldopa Dosage and Administration

Adult

Initially 250mg 2–3 times daily; titrate at intervals of at least 2 days. Concomitant antihypertensives other than thiazides: initial max 500mg/day. Maintenance: 500mg–2g/day in 2–4 divided doses; max 3g/day.

Children

Initially 10mg/kg per day in 2–4 divided doses; max 65mg/kg or 3g daily (whichever is less).

Methyldopa Contraindications

Contraindications

Active hepatic disease. History of methyldopa-associated liver dysfunction. Concomitant MAOIs.

Methyldopa Boxed Warnings

Not Applicable

Methyldopa Warnings/Precautions

Warnings/Precautions

Hepatic or renal dysfunction. Pheochromocytoma. Severe cerebrovascular disease. Monitor blood and liver function. Discontinue if fever, jaundice, liver dysfunction, worsening edema or heart failure occurs. Surgery. Pregnancy (Cat.B). Nursing mothers.

Methyldopa Pharmacokinetics

See Literature

Methyldopa Interactions

Interactions

MAOIs: see Contraindications. Antagonized by oral iron preps: not recommended. May potentiate antihypertensives, general anesthetics, lithium. May interfere with lab tests.

Methyldopa Adverse Reactions

Adverse Reactions

Sedation, headache, asthenia, orthostatic hypotension, bradycardia, edema, GI upset, rash, nasal congestion, arthralgia, amenorrhea, hyperprolactinemia, gynecomastia, pancreatitis, impotence, decreased libido, CNS effects, eosinophilia, liver dysfunction, jaundice, (+) Coombs test, hemolytic anemia; rarely: fatal hepatic necrosis, blood dyscrasias.

Methyldopa Clinical Trials

See Literature

Methyldopa Note

Notes

Formerly known under the brand name Aldomet.

Methyldopa Patient Counseling

See Literature